EuroIntervention/X
Jun 30, 2025, 15:19
Study Explored the Use of Paclitaxel-Coated Balloons for Stabilizing Vulnerable Lipid-Rich Plaques in ACS Patients – EuroIntervention
EuroIntervention shared on X:
“This study explored the use of paclitaxel-coated balloons for stabilizing vulnerable lipid-rich plaques in ACS patients. Discover how this approach could reduce future coronary events.”
Title: Paclitaxel-coated balloons for vulnerable lipid-rich plaques.
Authors: Anna van Veelen, I. Tarik Küçük, Hector M. García-García, Federico H. Fuentes, Yirga Kahsay, Ronak Delewi, Marcel A.M. Beijk, Alexander W. den Hartog, Maik J. Grundeken, M. Marije Vis, José P.S. Henriques, Bimmer E.P.M. Claessen.
Read the full research.
You can find more posts on Hemostasis Today.
-
Sep 10, 2026, 05:12Douglas S. Campbell: Great to See a Strong Japanese Presence in 2026 Lasker Awards
-
Sep 10, 2026, 05:11Jan Hartmann: New Transformative Treatment for Hemophilia A
-
Sep 10, 2026, 05:09Shelby Bradford: Award-Winning Science Incoming
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH